BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6544786)

  • 1. Inhibition of surface induced coagulation by preadsorption of albumin-heparin conjugates.
    Hennink WE; Kim SW; Feijen J
    J Biomed Mater Res; 1984 Oct; 18(8):911-26. PubMed ID: 6544786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of antithrombin III with preadsorbed albumin-heparin conjugates.
    Hennink WE; Ebert CD; Kim SW; Breemhaar W; Bantjes A; Feijen J
    Biomaterials; 1984 Sep; 5(5):264-8. PubMed ID: 6487709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient in vivo protein adsorption onto polymeric biomaterials.
    Ihlenfeld JV; Cooper SL
    J Biomed Mater Res; 1979 Jul; 13(4):577-91. PubMed ID: 88452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antithrombin III with surface-immobilized albumin-heparin conjugates.
    van Delden CJ; Engbers GH; Feijen J
    J Biomed Mater Res; 1995 Nov; 29(11):1317-29. PubMed ID: 8582900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein binding properties to immobilized heparin and heparin-albumin conjugate.
    Mirow N; Zimmermann B; Maleszka A; Knobl H; Tenderich G; Koerfer R; Herberg FW
    Artif Organs; 2007 Jun; 31(6):466-71. PubMed ID: 17537059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-adsorbed fibrinogen and fibrin may activate the contact activation system.
    Sanchez J; Elgue G; Larsson R; Nilsson B; Olsson P
    Thromb Res; 2008; 122(2):257-63. PubMed ID: 18177925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coating of commercially available materials with a new heparinizable material.
    Barbucci R; Albanese A; Magnani A; Tempesti F
    J Biomed Mater Res; 1991 Oct; 25(10):1259-74. PubMed ID: 1839834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of different heparin surface concentrations and antithrombin-binding capacity on inflammation and coagulation.
    Johnell M; Larsson R; Siegbahn A
    Biomaterials; 2005 May; 26(14):1731-9. PubMed ID: 15576147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modification of polymeric biomaterials by albumin grafting using h-irradiation.
    Kamath KR; Park K
    J Appl Biomater; 1994; 5(2):163-73. PubMed ID: 10147177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of heparinized polymer materials with plasma proteins and thrombocytes].
    Nemets EA; SevastĂ­anov VI
    Med Tekh; 1994; (2):18-22. PubMed ID: 8208096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antithrombogenicity of anionic polyurethanes and heparin-bound polyurethanes.
    Ito Y; Sisido M; Imanishi Y
    J Biomed Mater Res; 1986 Oct; 20(8):1157-77. PubMed ID: 3782177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
    Du YJ; Brash JL; McClung G; Berry LR; Klement P; Chan AK
    J Biomed Mater Res A; 2007 Jan; 80(1):216-25. PubMed ID: 17072855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalently bound conjugates of albumin and heparin: synthesis, fractionation and characterization.
    Hennink WE; Feijen J; Ebert CD; Kim SW
    Thromb Res; 1983 Jan; 29(1):1-13. PubMed ID: 6836542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood.
    Keuren JF; Wielders SJ; Willems GM; Morra M; Lindhout T
    Thromb Haemost; 2002 Apr; 87(4):742-7. PubMed ID: 12008960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual radiolabeling to study protein adsorption competition in relation with hemocompatibility.
    Nonckreman CJ; Rouxhet PG; Dupont-Gillain CC
    J Biomed Mater Res A; 2007 Jun; 81(4):791-802. PubMed ID: 17226808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characteristics of anticoagulation by covalently immobilized heparin.
    Miura Y; Aoyagi S; Kusada Y; Miyamoto K
    J Biomed Mater Res; 1980 Sep; 14(5):619-30. PubMed ID: 7349668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of polymeric coatings with combined nitric oxide release and immobilized active heparin.
    Zhou Z; Meyerhoff ME
    Biomaterials; 2005 Nov; 26(33):6506-17. PubMed ID: 15941584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of absorption of heparin-DOCA conjugates on the intestinal wall using a surface plasmon resonance.
    Kim SK; Kim K; Lee S; Park K; Park JH; Kwon IC; Choi K; Kim CY; Byun Y
    J Pharm Biomed Anal; 2005 Oct; 39(5):861-70. PubMed ID: 16143485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface modification with functionally active heparin.
    Riesenfeld J; Olsson P; Sanchez J; Mollnes TE
    Med Device Technol; 1995 Mar; 6(2):24-31. PubMed ID: 10155375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.